Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

Community social media sites massively more popular than those run by pharma

PwC study finds communities’ Facebook, Twitter and YouTube use shows 24 times more activity than the corresponding use of social media by health industry companies

Local authorities in England lack resources for public health comms

Nearly half of local authority comms heads feel insufficiently resourced to handle communications around public health 

- PMLiVE

Smokefree brief for Two Birds One Stone

NHS Wakefield appoints youth PR agency to handle Smokefree Wakefield campaign

- PMLiVE

VIDEO: Eisai manufacturing plans shows UK is recovering from ‘shock’ of Pfizer/AZ cutbacks

David Willetts says life sciences industry has future in UK at opening of Fycompa manufacturing site

Havas rebrands Euro RSCG network

Global rebranding exercise is intended to unify Havas agencies, with all Euro RSCG Life agencies now coming under a Havas Health (formerly known as Havas Worldwide Health) umbrella, and with...

- PMLiVE

Ketchum names new global healthcare practice director

Amanda Sefton has been promoted from MD of healthcare in London

FDA sets new date for Eliquis review in atrial fibrillation

US regulator had asked for more data from Pfizer and BMS

- PMLiVE

US government advisers urge FDA to speed up drug approval process

Calls for greater partnership between public and private sectors

Novartis drug effective in hard-to-treat psoriasis

Secukinumab to commence phase III trials

- PMLiVE

Kevin Bottomley to lead Results International’s healthcare division

Results Healthcare aims to build on Results International’s transaction experience in healthcare market access and healthcare communications

NHS reforms increase need for pharma to engage with all stakeholders

Industry and payers highlight the need to improve communications efforts across healthcare pathway

Novartis building

Novartis heart failure candidate clears phase III trial

Serelaxin proves effective in reducing all-cause mortality

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links